Nervio
PrivateLast Round
Seed
Sep 1, 2025
Total Funding Raised
$6.89M
Company Overview
Nervio operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in September 2025.
Nervio is a healthtech company that develops AI-powered intraoperative neuromonitoring solutions to assist surgical teams in preventing nerve injuries during complex surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nervio Comparables
Compare Nervio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| READE.ai | 84% | |
| NeuroVascular Research & Design | 83% | |
| Brainlab | 74% |
For institutional investors. Book with your work email.
Nervio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 1, 2025 | ||||
| Grant | Dec 1, 2024 | ||||
| Seed | Dec 30, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nervio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merchavia Holdings and Investments Ltd | Seed |
| Israel Innovation Authority | Grant |
| eHealth Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Monthly visitors increased 167% MoM, reaching 3.2K.
- Mar 2, 2026
Monthly visitors increased 108% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Nervio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nervio's valuation, stock price, and market status.
Is Nervio a public or private company?
Nervio is a private company.
What is the current stock price of Nervio?
Nervio is a private company, so its shares have no public market price. Caplight tracks Nervio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nervio worth (valuation)?
Valuation information for Nervio is not publicly available.
Can I buy Nervio stock?
Nervio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nervio's last funding round?
Nervio's most recent funding round was Seed on September 1, 2025.
Who are the main investors in Nervio?
Key investors in Nervio include Merchavia Holdings and Investments Ltd, Israel Innovation Authority, eHealth Ventures.
Will Nervio IPO soon?
No public IPO plans have been announced for Nervio.
How can I track Nervio secondary market activity?
Caplight tracks bids, offers, and trades in Nervio's shares on secondary markets.